BRISTOL MYERS SQUIBB CO (CELG-RI)
Pharmaceutical Preparations · Healthcare · $141.1B
Intrinsic Value (Consensus)
$48.07
Current Price
$69.20
Margin of Safety
-30.5%
30.5% Above Intrinsic Value
Value: $48
Price: $69
Valuation Model Estimates
Current Price: $69.20
DCF (Discounted Cash Flow)
$99.12
Graham Number
$26.56
Earnings Power Value
$33.59
Relative Value (P/E)
$69.20
Dividend Discount Model
$11.89
Consensus Value
$48.07
Model Assumptions
Discount Rate
10.3%
Growth Rate
5.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Key Financials
- EPS (TTM)
- $3.46
- EPS (Forward)
- $3.63
- Book Value
- $9.06
- P/E Ratio
- 20.0
- Forward P/E
- 19.0
- PEG Ratio
- —
- ROE
- 38.2%
- Debt/Equity
- 243%
- Revenue Growth
- -0.2%
- Earnings Growth
- 5.0%
- Dividend Yield
- 0.9%
- Beta
- 1.00
Data last updated: 2026-06-12
Source: Yahoo Finance